US News

Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced multiple presentations of clinical data from an ongoing Phase 1 trial of its lead drug candidate, Selinexor (KPT-330), in patients with hematologic malignancies at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. The data indicate that first-in-class oral...

As I sit down to begin this article, Friday is only and hour and a quarter away in London. A few short hours later, it will be business as usual, then off for the weekend. I would suggest that the occasional glance be given to Wall Street during the day, and after the LSE closes. […]

After writing yesterday about the S&P 500 reaching new heights, I was prepared to follow up today with a similar story. However, as I usually caution, what goes up must come down. Except that with the indexes it’s more like a kid blowing up a balloon. They get excited as it gets bigger and bigger, […]

The fireworks did not end Monday evening as the US Memorial Day weekend came to a close. They continued this morning on the New York Stock Exchange as the S&P 500 set a new intra-day record of 1,912.28 before closing at 1,911.91, up 11.38 and 0.6% from Friday’s close at 1,900.53. The previous high of […]

The U.S. Department of the Treasury has priced a secondary public offering of the remaining 1,085,554 shares of common stock of CommunityOne Bancorp (the Company) it holds at $9.35 per share. The aggregate net proceeds to Treasury from the offering are expected to be $10.1 million. After this offering, Treasury will no longer hold any […]

Phizer (NYSE:PFE) has officially withdrawn it’s £69 billion offer to acquire British pharmaceutical giant, AstaZeneca (LSE:AZN). According to a statement from Pfizer on 26 May, the deal has been withdrawn and, therefore, will not happen at any time in the near future, if ever. The text of Pfizer’s announcement read: On 18 May 2014, Pfizer announced […]

The latest offer from Pfizer (NYSE:PFE) for AstraZeneca (LSE:AZN) (NYSE:AZN) has turned into a Phizaster. No matter how loudly one shouts “No,” it usually causes other voices to cry out in protest. Whilst the original “No” was directed at Pfizer, now the AZN board is saying “No” to its own shareholders. That’s probably not a […]

Dividend of $0.15 Per Share Flushing Financial Corporation (Nasdaq:FFIC), the parent holding company for Flushing Bank, today announced that the Board of Directors declared a quarterly dividend on its common stock of $0.15 per common share, payable on June 27, 2014 to shareholders of record at the close of business on June 6, 2014. John […]

Relates to Common Stok Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the pricing of an underwritten public offering of 7,300,000 shares of its common stock at a price to the public of $14.22 per share. The gross proceeds to Chimerix from this offering, […]

Extended to US$2.75m Magnolia Petroleum Plc, the AIM quoted US onshore focused oil and gas exploration and production company, has announced the borrowing base limit of its Credit Facility has been increased to US$2.75 million from US$2.1 million. This development follows the recent increase in the value of the Company’s net attributable proved and developed […]